RegenoGel is a novel injectable viscoelastic gel that provides rapid, long-term pain relief and promotes regenerative healing of damaged cartilage due to degenerative joint disease or trauma. This effective, minimally invasive and safe solution promises new hope to patients suffering from pain and disability.
RegenoGel brings together two materials to create a novel “super” material. Using Procore’s proprietary platform technology, RegenoGel combines natural high molecular weight hyaluronic acid (HA) chemically linked to fibrinogen, a major plasma regulator of hemostasis and wound healing. This “perfect marriage” of non animal derived materials creates a highly safe and stable product. RegenoGel therefore shares the viscoelastic, protective and anti-inflammatory properties of HA with a fibrinogen-based matrix, to create a unique bio-compatible environment that stimulates the body’s own physiological regenerative processes.
RegenoGel acts in two phases. First, as a non-viscous liquid easily administered through a fine needle, it freely flows and spreads within the joint, filling fissures and cracks. Once settled into the damaged tissue, it transforms into a non-soluble stable gel. This transformation from liquid to solid dramatically enhances its supportive and soothing properties, providing lubrication and dissipating pressure to alleviate pain. Enriched with fibrinogen, this bio-environment is uniquely conducive to regenerative healing and optimal for natural tissue regeneration.
